Menu
Recruiting NCT07006155

Biograph Vision 600 Versus Biograph Vision.X PET/CT

No phase Interventional Cancer Alzheimer Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Images.
Who it may be relevant to
Registry conditions: Cancer, Alzheimer Disease. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Intra-individual Comparison of PET Scans on the Biograph Vision 600 With the New Biograph Vision.X PET/CT

Overview

The main purpose is to evaluate initial clinical experiences and to explore whether the Vision.X system yields improved image quality and diagnostic performance compared to Vision 600.

Interventions

  • Device Images
    PET/CT images

Primary outcome measures

  • change of physician's diagnostic confidence [Time frame: through study completion , an average of 1 year]
Secondary outcome measures (1)
  • lowering of the radiotracer activity [Time frame: through study completion , an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Written Inform Consent to participating.
  • 18 to 85 years of age
  • Willing and able to comply with the requirements of the study, as judged by the investigator

Exclusion criteria

  • Women in pregnancy
  • Patients unable to lie still for the duration of the examination

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Crossover
Masking
Open label
Primary purpose
Diagnostic

Study locations

Switzerland · 1 center
  • Hopitaux Universitaires de Genève — Geneva

Identifiers

NCT: NCT07006155 · 2025-D00005

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗